News HiDoc raises $7m and names new CEO as digital tool for IBS l... HiDoc Technologies has secured a cash injection of $7 million to help with the launch of its Cara Care digital therapeutic for people with
News Indegene backs launch of metaMe's DTx for irritable bowel sy... metaMe Health has enlisted the aid of health tech company Indegene to launch its recently-approved prescription digital therapeutic (DTx) Regulora for irritable bowel syndrome in the US.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face